KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Current Taxes: 2010-2018

Historic Current Taxes for Biomarin Pharmaceutical (BMRN) over the last 9 years, with Dec 2018 value amounting to $7.8 million.

  • Biomarin Pharmaceutical's Current Taxes rose 11.06% to $11.4 million in Q1 2019 from the same period last year, while for Mar 2019 it was $11.4 million, marking a year-over-year increase of 11.06%. This contributed to the annual value of $7.8 million for FY2018, which is 20.07% down from last year.
  • According to the latest figures from FY2018, Biomarin Pharmaceutical's Current Taxes is $7.8 million, which was down 20.07% from $9.7 million recorded in FY2017.
  • In the past 5 years, Biomarin Pharmaceutical's Current Taxes ranged from a high of $59.6 million in FY2015 and a low of $5.5 million during FY2014.
  • Its 3-year average for Current Taxes is $8.5 million, with a median of $7.8 million in 2016.
  • Per our database at Business Quant, Biomarin Pharmaceutical's Current Taxes soared by 987.28% in 2015 and then slumped by 86.83% in 2016.
  • Over the past 5 years, Biomarin Pharmaceutical's Current Taxes (Yearly) stood at $5.5 million in 2014, then surged by 987.28% to $59.6 million in 2015, then slumped by 86.83% to $7.8 million in 2016, then increased by 24.11% to $9.7 million in 2017, then fell by 20.07% to $7.8 million in 2018.